ADEL K EL-NAGGAR to Bone Neoplasms
This is a "connection" page, showing publications ADEL K EL-NAGGAR has written about Bone Neoplasms.
Connection Strength
0.359
-
Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors. J Clin Oncol. 2017 Jan 20; 35(3):352-360.
Score: 0.056
-
Primary intraosseous mucoepidermoid carcinoma of the jaw: Reappraisal of The MD Anderson Cancer Center experience. Head Neck. 2016 04; 38 Suppl 1:E1312-7.
Score: 0.052
-
DNA and RNA content analysis by flow cytometry in the pathobiologic assessment of bone tumors. Cytometry. 1995 Mar 01; 19(3):256-62.
Score: 0.050
-
Pla2g16 phospholipase mediates gain-of-function activities of mutant p53. Proc Natl Acad Sci U S A. 2014 Jul 29; 111(30):11145-50.
Score: 0.048
-
Differential gene expression profiling of aggressive and nonaggressive follicular carcinomas. Hum Pathol. 2011 Sep; 42(9):1213-20.
Score: 0.038
-
Melanoma in a carcinoma ex pleomorphic adenoma of the parotid gland: a case report and putative histogenesis. Hum Pathol. 2011 Sep; 42(9):1355-8.
Score: 0.038
-
Primary hyperparathyroidism and osteosarcoma: examination of a large cohort identifies three cases of fibroblastic osteosarcoma. J Bone Miner Res. 2005 Sep; 20(9):1562-8.
Score: 0.025
-
Radiotherapy in the management of giant cell tumor of bone. Int J Radiat Oncol Biol Phys. 2003 Sep 01; 57(1):158-65.
Score: 0.023
-
Differential Gain-of-Function Activity of Three p53 Hotspot Mutants In Vivo. Cancer Res. 2022 05 16; 82(10):1926-1936.
Score: 0.021
-
Giant cell tumor of bone. A clinicopathologic and DNA flow cytometric analysis. Cancer. 1990 Nov 15; 66(10):2186-90.
Score: 0.009